Phyllanthostatin I
Alternative Names: NSC 328426; Phyllanthoside; PhyllanthostatinLatest Information Update: 26 Oct 1994
Price :
$50 *
At a glance
- Originator National Cancer Institute (USA)
- Class Antineoplastics; Antivirals
- Mechanism of Action DNA synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 26 Oct 1994 NSC 328426's new name is phyllanthostatin I.